VASAMED, Inc.
VSMD
$0.00
$0.000.00%
| 06/30/2009 | 03/31/2009 | 12/31/2008 | 09/30/2008 | 06/30/2008 | |
|---|---|---|---|---|---|
| Revenue | -7.15% | 56.92% | 72.55% | 10.72% | 67.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.15% | 56.92% | 72.55% | 10.72% | 67.23% |
| Cost of Revenue | -5.50% | 19.20% | -29.37% | -7.99% | 18.23% |
| Gross Profit | -9.03% | 105.57% | 348.40% | 33.89% | 217.78% |
| SG&A Expenses | -30.52% | -44.20% | -36.71% | -22.11% | 7.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.87% | -25.33% | -30.97% | -18.67% | 2.65% |
| Operating Income | 41.99% | 70.71% | 79.51% | 40.07% | 25.24% |
| Income Before Tax | 35.06% | 63.50% | 71.94% | 59.62% | 50.09% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 35.06% | 63.50% | 71.94% | 59.62% | 50.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.06% | 63.50% | 71.94% | 59.62% | 50.09% |
| EBIT | 41.99% | 70.71% | 79.51% | 40.07% | 25.24% |
| EBITDA | 42.23% | 72.92% | 82.33% | 41.81% | 25.85% |
| EPS Basic | 35.05% | 63.53% | 71.95% | 80.58% | 75.97% |
| Normalized Basic EPS | 34.98% | 63.51% | 71.91% | 80.59% | 75.99% |
| EPS Diluted | 35.05% | 63.53% | 71.95% | 80.58% | 75.97% |
| Normalized Diluted EPS | 34.98% | 63.51% | 71.91% | 80.59% | 75.99% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 107.82% | 107.82% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 107.82% | 107.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
